Chester County News and Community Website
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) revealed new insights from a post hoc data analysis of its Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for …
Endo, Inc. Shares Positive Data on XIAFLEX Treatment for Peyronie’s Disease Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has launched its new television commercial and disease awareness campaign, “I Got Somebody,” to encourage men experiencing symptoms of Peyronie’s disease (PD) to take …
Endo, Inc. Launches “I Got Somebody” Campaign to Raise Awareness About Peyronie’s Disease Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has introduced a new tool to support men dealing with Peyronie’s disease (PD). The self-assessment screening app, designed to help individuals identify and …
ICYMI: New App Helps Men Address Peyronie’s Disease Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has introduced a free self-assessment app designed to help men manage Peyronie’s disease (PD), a condition involving penile curvature that can be both …
New App Aims to Empower Men with Peyronie’s Disease Read More MALVERN, PA — At the recent American Urological Association (AUA) annual meeting held from May 3-6, 2024, Endo, Inc. took the spotlight with the unveiling of new research on Peyronie’s …
Innovations in Peyronie’s Disease Treatment Highlighted at AUA Annual Meeting Read More